Made In USAFor Laboratory Research OnlyCOAs Not Yet AvailableExplore Compound Research ProfilesCompare Catalog SizesResearch Requests Reviewed IndividuallyNot For Human Or Veterinary Use
Single compound

SNAP-8

Catalog size
$33
USD per vial · 10 mgCatalog price
Research only

SNAP-8 denotes acetyl octapeptide-3, studied within multicomponent cosmetic formulations; those studies cannot isolate its effects or establish the mechanism proposed from related hexapeptide research.

Explore the research profile

Submit an unpaid laboratory order request for manual review. Availability and any pending amounts require confirmation.

No reservation or purchase is made by adding a material.
View documentation status ← Back to collection
Material
SNAP-8
Format
Awaiting confirmation
Availability
Confirmed during review

Catalog quantities are not assay results.

In the literature

A closer look at the science.

Synthetic acetylated cosmetic octapeptide

What is SNAP-8?

Acetyl octapeptide-3 is an eight-residue peptide with an acetylated N terminus and amidated C terminus, described as Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2. SNAP-8 is distinct from the six-residue peptide Argireline. Similar sequence elements do not make the two compounds interchangeable in either a biological assay or an interpretation of clinical evidence.

Reference identity
Research class
Synthetic acetylated cosmetic octapeptide
Catalog search names
SNAP8
Chemical name
Acetyl octapeptide-3
Residue count
Eight residues
Sequence notation
Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2
Terminal chemistry
Acetylated N terminus; amidated C terminus

This reference describes the published literature. Exact supplied form and chemical specifications require product-specific documentation. The studies are linked in Selected literature.

Mechanisms under investigation

A commonly proposed rationale concerns interference with proteins involved in neurotransmitter release. Primary experiments with Argireline examined SNARE-complex formation and secretion, but that work tested the hexapeptide. The cited octapeptide formulation studies measured skin outcomes and did not independently establish direct SNARE inhibition, neuromuscular effects, or relative potency for isolated SNAP-8.

Documented lines of inquiry

Research areas

  1. 01

    Controlled cosmetic formulation assessment

    A 2024 study enrolled 24 people and compared a mixed-ingredient dissolving microneedle patch with a hyaluronic-acid control patch. Skin measurements favored the active formulation on several outcomes, but the octapeptide was accompanied by two other functional ingredients. [1]

  2. 02

    Longer formulation observation

    A separate 12-week study assessed a microneedle formulation containing multiple peptides, adenosine, and seaweed extracts. Reported skin-property changes describe the complete product, leaving the octapeptide's individual contribution and interactions unresolved. [2]

  3. 03

    Related peptide mechanism research

    An earlier Argireline study investigated neurotransmitter release and skin topography. It provides scientific context for a family of cosmetic peptide hypotheses. Its molecular and clinical findings cannot be reassigned to the chemically different octapeptide. [3]

Study topics describe the cited models, not established benefits of this catalog material.

Reading the evidence

What the studies
can tell us.

Human formulation studies; isolated effect unresolved

The strongest directly relevant human evidence concerns products containing acetyl octapeptide-3, rather than a test isolating it as the sole experimental variable. Delivery technology, other ingredients, and formulation properties could each contribute to the observed outcomes.

What remains uncertain

These papers do not establish an independent wrinkle-reduction magnitude, systemic pharmacology, or long-term safety profile for SNAP-8. They also do not support extrapolation from a tested cosmetic product to a research vial, another preparation, or a different route of exposure.

Read the source

Selected literature

Primary studies and clearly identified supporting sources. Each link opens the original record.

  1. 01
    2024 · Human formulation trial

    Clinical Safety and Efficacy Evaluation of a Dissolving Microneedle Patch Having Dual Anti-Wrinkle Effects With Safe and Long-Term Activities (opens a new tab)

    Mixed formulation containing acetyl octapeptide-3; 24 enrolled participants, with no isolated-peptide comparison.

    PubMed
  2. 02
    2020 · Human formulation study

    Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches: A monocentric clinical study (opens a new tab)

    Multicomponent cosmetic patch; final publication 2020, online 2019; cannot identify SNAP-8's individual effect.

    PubMed
  3. 03
    2002 · Cell and human formulation study

    A synthetic hexapeptide (Argireline) with antiwrinkle activity (opens a new tab)

    Related six-residue peptide, not SNAP-8; included only to explain the limits of transferring proposed mechanisms.

    PubMed

Literature reviewed October 2026. This is a selected research overview, not an exhaustive systematic review. Published findings do not establish the identity, purity, sterility or suitability of any WYZ batch. For laboratory research only; not for human or veterinary use.

Before you begin

The details behind
the material.

Specifications and storage

Final product specifications and product-specific storage instructions have not been supplied. Review the original documentation and your laboratory’s procedures before obtaining or using the material.

Research use only

For qualified laboratory researchers. Not for human or veterinary use. Product information is not medical advice or a recommendation for personal use.

What to look for in a COA
Before you explore

Laboratory
research only.

Please confirm the following to enter the Wyz Labs collection.

Select both confirmations to continue.

Your acknowledgment is remembered for this browser session. This is a self-declaration, not identity verification.